TickerFactsScreenerDevelopers

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2007: $225.45M2008: $243.59M2009: $182.57M2010: $179.16M2011: $68.91M2012: $109.69M2013: $155.93M2014: $160.02M2015: $117.95M2016: $117.63M2017: $163.79M2018: $195.44M2019: $238.01M2020: $228.42M2021: $241.21M2022: $233.91M2023: $276.77M2024: $194.61M2025: $213.77M$213.77M
2007Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$213.77M+9.8%
2024$194.61M-29.7%
2023$276.77M+18.3%
2022$233.91M-3.0%
2021$241.21M+5.6%
2020$228.42M-4.0%
2019$238.01M+21.8%
2018$195.44M+19.3%
2017$163.79M+39.2%
2016$117.63M-0.3%
2015$117.95M-26.3%
2014$160.02M+2.6%
2013$155.93M+42.2%
2012$109.69M+59.2%
2011$68.91M-61.5%
2010$179.16M-1.9%
2009$182.57M-25.0%
2008$243.59M+8.0%
2007$225.45M—